Malignant epithelial cell marker–driven risk signature enables precise stratification in esophageal cancer
BackgroundEsophageal squamous cell carcinoma (ESCC) is a highly heterogeneous malignancy. Traditional clinical staging systems have limited value in prognostic evaluation and treatment guidance, often failing to capture the profound impact of intratumoral diversity on patient outcomes. Single-cell R...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610991/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|